Skip to content

usecure

A Manchester, UK human risk management platform bundling security awareness training, phishing simulation, policy management, and dark-web monitoring, sold primarily through a 1,800+ MSP partner channel.

Visit Website ↗ + Add to Compare
57/100Incremental Innovator

Overview

usecure is a Manchester, UK-based “human risk management” platform that bundles security-awareness training (branded uLearn), simulated phishing, policy management and attestation, and dark-web credential-exposure monitoring into a single product. Its go-to-market is heavily channel-first: usecure sells overwhelmingly through managed service providers (MSPs) reselling security services to small and mid-sized businesses, rather than direct enterprise sales.

Founded in 2016, usecure has raised a Series A round backed by Kennet Partners and reports supporting hundreds of thousands of end users through more than 1,800 MSP partners globally. That MSP-first design — multi-tenant management and white-labeling built for partners rather than end customers — is usecure’s main differentiator in an otherwise crowded field.

Security-awareness training and phishing simulation is a mature category dominated by much larger players such as KnowBe4 and Proofpoint, alongside numerous smaller entrants. usecure competes less on training methodology than on being purpose-built for MSP delivery at scale, with independent (if self-selected) user feedback visible on platforms like G2 and Gartner Peer Insights.

Innovation Matrix Assessment

Innovation Velocity 6/10

Has continued expanding its bundled product line (uLearn, phishing simulation, policy management, dark-web monitoring), evidenced by its own product pages and content cadence, though no independent release-cadence data exists.

Operational Value 7/10

An explicit multi-tenant, white-label design and a reported base of 1,800+ MSP partners is a meaningful, verifiable-in-principle signal that the platform is built for at-scale channel delivery rather than only single-tenant deployments.

Market Momentum 6/10

A Series A round with a named institutional investor (Kennet Partners) and a stated base of 'hundreds of thousands' of end users are real signals, though no funding round more recent than the Series A was found, so the growth signal is somewhat dated.

Category Disruption 4/10

Security-awareness and phishing-simulation is a mature, heavily-competed category; usecure's bundling and MSP-channel focus is an incremental go-to-market differentiator rather than a technically disruptive approach.

Real-World Efficacy 5/10

Independent user reviews exist on G2 and Gartner Peer Insights (third-party platforms, though self-selected and not lab-tested); no controlled efficacy study, such as independently validated phishing-click-rate reduction data, was found.

Enduring Relevance 6/10

Human error and phishing remain leading breach vectors industry-wide, keeping awareness and simulation platforms relevant, though the category is now table-stakes rather than differentiating for most buyers.

Why CISOs Should Care

usecure is a reasonable fit for CISOs at smaller organizations buying security awareness training through an MSP rather than running the program in-house, given its explicit multi-tenant, MSP-first design.

What Makes It Different

Purpose-built for MSP and channel delivery, with white-labeling and multi-tenant management for 1,800+ partners, rather than a direct-to-enterprise tool retrofitted for MSPs.

The Matrix Verdict

57/100 — INCREMENTAL INNOVATOR

A capable, MSP-channel-focused human risk management platform in a mature and crowded category, competing on delivery model and pricing for the SMB/MSP segment rather than on novel training technology.

Editorial Note: Claims vs. Verified Findings

The '1,800+ MSP partners' and 'hundreds of thousands of end users' figures are self-reported by usecure and not independently audited. The Series A round and Kennet Partners investment are independently corroborated via Crunchbase/CB Insights, and G2/Gartner Peer Insights reviews are third-party but self-selected rather than controlled studies.

Sources